Sun Pharma gets USFDA nod for drug to treat neonatal seizures
"With this approval, SEZABY becomes the first and only product specifically indicated in the US for the treatment of neonatal seizures in term and pre-term infants," the company said. The drug is expected to be available in the US in the fourth quarter of FY23, it added.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Z4LlwfU
via IFTTT
IHH says Sebi has advised it to go ahead with Fortis open offer after getting High Court order
It however reaffirmed its commitment towards its investors and the India healthcare sector, and said that it will make appropriate announcement to Malaysia’s stock exchange in a timely manner, it further said.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RHU3rJW
via IFTTT
Sebi advices IHH Healthcare to proceed with open offer to acquire stake in Fortis after Delhi HC's order
Sebi on Thursday advised Malaysia's IHH Healthcare to go ahead with its open offer to acquire 26.1 per cent market share in Fortis Healthcare after obtaining order from the Delhi High Court, the company stated. In November 2018, IHH Healthcare had acquired 31.17 per cent stake in Fortis by infusing fresh capital of Rs 4,000 crore.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/7BIJax0
via IFTTT
Manipal Hospitals announces setting up of a hospital facility in Chhattisgarh
The greenfield facility would add to Manipal Hospital’s network of 28 hospitals spread across 15 cities with over 7,800 beds and a talent pool of 4,000 doctors and over 11,000 employees, the hospital said in a press release.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/zg8JdfV
via IFTTT